Xu H - Search Results

1

Lack of adiponectin and adiponectin receptor 1 contributes to benign prostatic hyperplasia.

Fu S, Xu H, Gu M, Liu C, Wan X, Chen Y, Chen Q, Zhou J, Wang Z. Fu S, et al. Among authors: xu h. Oncotarget. 2017 Aug 3;8(51):88537-88551. doi: 10.18632/oncotarget.19877. eCollection 2017 Oct 24. Oncotarget. 2017. PMID: 29179455 Free PMC article.

2

Smoking habits and benign prostatic hyperplasia: A systematic review and meta-analysis of observational studies.

Xu H, Fu S, Chen Y, Chen Q, Gu M, Wang Z. Xu H, et al. Medicine (Baltimore). 2016 Aug;95(32):e4565. doi: 10.1097/MD.0000000000004565. Medicine (Baltimore). 2016. PMID: 27512883 Free PMC article. Review.

3

Prostatic vascular damage induced by cigarette smoking as a risk factor for recovery after holmium laser enucleation of the prostate (HoLEP).

Xu H, Liu C, Gu M, Chen Y, Cai Z, Chen Q, Wang Z. Xu H, et al. Oncotarget. 2017 Feb 21;8(8):14039-14049. doi: 10.18632/oncotarget.12538. Oncotarget. 2017. PMID: 27732940 Free PMC article.

4

Oxytocin: its role in benign prostatic hyperplasia via the ERK pathway.

Xu H, Fu S, Chen Y, Chen Q, Gu M, Liu C, Qiao Z, Zhou J, Wang Z. Xu H, et al. Clin Sci (Lond). 2017 Apr 1;131(7):595-607. doi: 10.1042/CS20170030. Epub 2017 Jan 27. Clin Sci (Lond). 2017. PMID: 28130436

5

Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity.

Fu S, Xu H, Gu M, Liu C, Wang Q, Wan X, Chen Y, Chen Q, Peng Y, Cai Z, Zhou J, Wang Z. Fu S, et al. Among authors: xu h. Sci Rep. 2017 Mar 3;7:43771. doi: 10.1038/srep43771. Sci Rep. 2017. PMID: 28256562 Free PMC article.

6

The function of oxytocin: a potential biomarker for prostate cancer diagnosis and promoter of prostate cancer.

Xu H, Fu S, Chen Q, Gu M, Zhou J, Liu C, Chen Y, Wang Z. Xu H, et al. Oncotarget. 2017 May 9;8(19):31215-31226. doi: 10.18632/oncotarget.16107. Oncotarget. 2017. PMID: 28415720 Free PMC article.

7

["3+1" bladder function restoration combined with holmium laser enucleation of the prostate for benign prostatic hyperplasia with acontractile detrusor].

Wan X, Liu C, Xu H, Gu M, Chen YB, Peng YB, Chen Q, Cai ZK, Wang Z. Wan X, et al. Among authors: xu h. Zhonghua Nan Ke Xue. 2017 Oct;23(10):912-916. Zhonghua Nan Ke Xue. 2017. PMID: 29727542 Chinese.

8

Hypoxia-inducible factor 1α (HIF-1α) mediates the epithelial-mesenchymal transition in benign prostatic hyperplasia.

Chen Y, Xu H, Shi Q, Gu M, Wan X, Chen Q, Wang Z. Chen Y, et al. Among authors: xu h. Int J Clin Exp Pathol. 2019 Jan 1;12(1):295-304. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31933745 Free PMC article.

9

Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer.

Xu H, Chen Y, Gu M, Liu C, Chen Q, Zhan M, Wang Z. Xu H, et al. Metabolites. 2021 Nov 9;11(11):765. doi: 10.3390/metabo11110765. Metabolites. 2021. PMID: 34822423 Free PMC article. Review.

10

A prospective randomized controlled trial comparing the effect and safety of Piranha and VersaCut morcellation devices in transurethral holmium laser enucleation of the prostate.

Chen Y, Xu H, Gao D, Gu M, Liu C, Zhan M, Cai Z, Chen Q, Wang Z. Chen Y, et al. Among authors: xu h. Int Urol Nephrol. 2022 Nov;54(11):2977-2981. doi: 10.1007/s11255-022-03218-0. Epub 2022 May 21. Int Urol Nephrol. 2022. PMID: 35596886 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,717 results

Search Page

Filters